Pila Pharma AB (publ) (STO:PILA)

Pila Pharma AB Statistics

Total Valuation

Pila Pharma AB has a market cap or net worth of SEK 89.64 million. The enterprise value is 88.56 million.

Market Cap	89.64M
Enterprise Value	88.56M

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Pila Pharma AB has 42.08 million shares outstanding. The number of shares has increased by 14.01% in one year.

Current Share Class	42.08M
Shares Outstanding	42.08M
Shares Change (YoY)	+14.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.57%
Owned by Institutions (%)	7.05%
Float	31.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	93.58
PB Ratio	77.34
P/TBV Ratio	144.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.87
EV / Sales	92.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.95

Current Ratio	0.95
Quick Ratio	0.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-893.87

Financial Efficiency

Return on equity (ROE) is -602.96% and return on invested capital (ROIC) is -271.76%.

Return on Equity (ROE)	-602.96%
Return on Assets (ROA)	-127.45%
Return on Invested Capital (ROIC)	-271.76%
Return on Capital Employed (ROCE)	-700.44%
Revenue Per Employee	957,889
Profits Per Employee	-11.26M
Employee Count	1
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.55% in the last 52 weeks. The beta is 0.41, so Pila Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-48.55%
50-Day Moving Average	2.20
200-Day Moving Average	2.63
Relative Strength Index (RSI)	51.86
Average Volume (20 Days)	286,651

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pila Pharma AB had revenue of SEK 957,889 and -11.26 million in losses. Loss per share was -0.41.

Revenue	957,889
Gross Profit	179,889
Operating Income	-8.12M
Pretax Income	-11.26M
Net Income	-11.26M
EBITDA	-7.04M
EBIT	-8.12M
Loss Per Share	-0.41

Balance Sheet

The company has 1.08 million in cash and n/a in debt, with a net cash position of 1.08 million or 0.03 per share.

Cash & Cash Equivalents	1.08M
Total Debt	n/a
Net Cash	1.08M
Net Cash Per Share	0.03
Equity (Book Value)	1.16M
Book Value Per Share	0.04
Working Capital	-107,000

Cash Flow

Operating Cash Flow	-8.22M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	18.78%
Operating Margin	-847.50%
Pretax Margin	-1,175.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pila Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.01%
Shareholder Yield	-14.01%
Earnings Yield	-12.56%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pila Pharma AB has an Altman Z-Score of -17.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.09
Piotroski F-Score	2